Podcasts · Core IM | Internal Medicine Podcast
#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
· 22 min
Episode #136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?
Sponsors: Post Investment: Real Estate Syndications || Hellofresh
Show Notes & Transcript
• 02:08 Framework for thinking about obesity • 03:42 History of obesity treatment • 06:29 Gila monsters and GLP and GIP mechanisms • 08:29 Story of how medications for diabetes were found to have a weight loss benefit • 12:50 SURMOUNT-1 trial
Tags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistant
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Eko: https://ekohealth.com * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
Links in the notes 5
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.